Apogem Capital closes RLP II Vision at $137.4M for institutional private equity investors
Apogem Capital's RLP II Vision LP, a Delaware private equity fund, closed a $137.4M offering to 12 qualified institutional investors under Regulation 3(c)(7). The fund reached its target and is now fully deployed as of October 2026.
How this compares
- $137.4M is larger than 84% of the 3,029 private equity / buyout fund launches with a stated size in the last two years; the median is $5M.
- Among 1,695 fund launches filed from NY in the same window it is larger than 88%; the NY median is $5M.
- Across 499 private equity / buyout sponsors with more than one launch on EDGAR, the median gap between consecutive funds is 5 months.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
People on the filing
| N/A RLP II Vision GP LLC | Director |
| John M. Grady | Executive Officer |
| Michael Lunt | Executive Officer |
| Michael Zeleniuch | Executive Officer |
| Doug Amache | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by John Grady, CFO of Apogem Capital LLC the Investment Manager.
Placement agents / sales compensation: NY Life Distributors LLC
Why now — by persona
- Fund administrator:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Fund audit & tax:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Compliance consultant / RIA registration:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.